Document is current

Article History

Received: 12 January 2024

Accepted: 4 November 2024

First Online: 3 December 2024

Declarations

:

: The POND study was approved by each participating institution’s research ethics boards; written informed consent or assent was obtained from the primary caregiver or participant where appropriate.

: Not applicable.

: All co-authors meet the requirements for authorship and have reviewed and approved this manuscript. Dr Kushki is the inventor of a software called the "holly". She is involved in commercialising holly (patents US 9,844,332 B2 and US 16/276,208 (pending)) and will financially benefit from its sales. Dr Kushki served on the board of advisors for Shaftesbury, a media company developing virtual reality products for autistic children, from February 2020 to February 2021, and was compensated financially for this role. She has also received consulting fees from a company, DNAStack. Dr Kushki has received donations of hardware for her research program from Samsung Canada. Dr Anagnostou reports grants from Roche, grants from Anavex, personal fees from Roche, personal fees from Quadrant, personal fees from Impel, personal fees from Ono, personal fees from Wiley, book royalties from Springer, book royalties from APPI, and non-financial support from AMO Pharma outside the submitted work. In addition, Dr Anagnostou holds a patent on the software called the “Anxiety Meter”; the Anxiety Meter is being commercialised and she will financially benefit from its sales. The other authors report no potential conflicts of interest.